BIOF 084 | Pharmacometric Dose-Response Analyses in Clinical Trials Using R
In order for a drug to get approved by the FDA for market in the USA, the sponsor must ultimately demonstrate the drug has: 1) a predictable exposure profile with dose, 2) a good safety profile, and 3) is effective at safe doses. Therefore, the pharmacology of a drug is essentially being reviewed by the [....]